| Structure |
Chemical Name |
CAS |
MF |
 |
Ozagrel methylester |
866157-50-8 |
C13H12N2O2 |
 |
オルト-メトプロロール |
163685-38-9 |
C15H25NO3 |
 |
TAZOBACTAM RELATED COMPOUND A ((2S,3S)-2-アミノ-3-メチル-3-スルフィノ-4-(1H-1,2,3-トリアゾール-1イル)酪酸) |
118175-11-4 |
C7H12N4O4S |
![1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]-](/CAS/20150408/GIF/104395-69-9.gif) |
1,4,8,11-Tetraazacy clotetradecance, 1,4,8-tris[(4 Methylphenyl)sufonyl]- |
104395-69-9 |
C31H42N4O6S3 |
![(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド](/CAS/GIF/177793-79-2.gif) |
(1S)-N-(3S)-1-アザビシクロ[2.2.2]オクト-3-イル-1,2,3,4-テトラヒドロ-1-ナフタレンカルボキサミド |
177793-79-2 |
C18H24N2O |
 |
(E)-セフトリアキソン |
92143-31-2 |
C18H18N8O7S3 |
 |
(Z)-シンナリジン |
750512-44-8 |
C26H28N2 |
 |
5-BroModescyano CitalopraM |
64169-39-7 |
C19H21BrFNO |
 |
Deschloro Cetirizine Dihydrochloride |
83881-54-3 |
C21H26N2O3 |
 |
DesvancosaMinyl VancoMycin |
101485-50-1 |
C59H62Cl2N8O22 |
 |
アセトロール |
57898-80-3 |
C14H22N2O3 |
 |
RAC-クロピドグレル-MP ENDO誘導体 |
1346598-12-6 |
C25H26ClNO6S |
![1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine](/CAS/20140608/GIF/CB82544399.gif) |
1,1'-N-[Methylenebis(sulphanediylethylene)]bis(N'-Methyl-2-nitroethene-1,1-diaMine |
1331637-48-9 |
C11H22N6O4S2 |
 |
2′,3′-ジデオキシ-3′-チアシチジン |
134680-32-3 |
C8H11N3O3S |
 |
Formoterol O-β-D-Glucuronide |
615551-59-2 |
C25H32N2O10 |
 |
Mono-POC Tenofovir 6-Isopropyl CarbaMate |
1244022-56-7 |
C18H28N5O9P |
 |
N-Methyl Iso Desloratadine |
183198-48-3 |
C20H21ClN2 |
 |
酒石酸イソプロピルエステル |
116601-09-3 |
C7H12O6 |
 |
Rivaroxaban Impurity 11 |
1411775-06-8 |
C14H17N3O4 |
 |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate |
|
C25H35NO3 |
 |
Flomoxef Impurity 4 |
|
|
 |
Nicardipine Impurity 5 |
|
|
![11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE](/CAS/GIF/263366-81-0.gif) |
11,11'-(PIPERAZINE-1,4-DIYL)-BIS-8-CHLORO-5H-DIBENZE[B,E][1,4]-DIAZEPINE |
263366-81-0 |
C30H24Cl2N6 |
 |
Sacubitril Impurity 7 |
149709-44-4 |
C22H25NO5 |
 |
Valsartan Impurity 5 |
1266616-11-8 |
C18H21N5 |
 |
Milnacipran Impurity 4 |
1353644-49-1 |
C15H21NO2 |
 |
2-アミノ-2-(4-ヘプチルフェネチル)-1,3-プロパンジオール |
745767-97-9 |
C18H31NO2 |
 |
Tenofovir Fumarate |
1246812-23-6 |
C21H34N5O9P |
 |
Prucalopride Impurity C |
1599434-55-5 |
C17H24ClN3O3 |
![1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/CAS/20200401/GIF/2205053-60-5.gif) |
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2205053-60-5 |
C21H24FN3O4 |
 |
Brexpiprazole N-Oxide |
1191900-58-9 |
C25H27N3O3S |
 |
2,6-Dibenzyloxyacetophenone |
3886-19-9 |
C22H20O3 |
![6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル](/CAS/20180703/GIF/1059630-08-8.gif) |
6-ブロモ-3,4,4A,5-テトラヒドロ-1H-ピリド[4,3-B]インドール-2(9BH)-カルボン酸(4AS,9BR)-エチル |
1059630-08-8 |
C14H17BrN2O2 |
 |
diphenhydramine impurity |
|
C17H21NO |
![1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide](/CAS/20180703/GIF/CB83146796.gif) |
1,1-dimethyl-4-(2-methyl-10H-benzo[b]thieno[2,3-e][1,4]diazepin-4-yl)piperazin-1-ium iodide |
|
C18H23IN4S |
 |
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid |
1657014-33-9 |
C16H16N2O3S |
 |
vildagliptin Impurity O |
2253194-12-4 |
C12H18N4O2 |
![methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-17-9.gif) |
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-17-9 |
C21H26N2O3 |
 |
Canagliflozin Impurity 17 |
1951467-28-9 |
C24H23FO6S |
 |
Canagliflozin Impurity 22 |
|
|
 |
Carfilzomib Impurity 3 |
|
|
 |
Dolutegravir Impurity 4 |
|
|
 |
Febuxostat Impurity 20 |
|
|
 |
Lenvatinib Impurity 1 |
|
|
![methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20211123/GIF/83508-82-1.gif) |
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
83508-82-1 |
C21H26N2O3 |
![4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester](/CAS/20180703/GIF/1941177-45-2.gif) |
4-[6-[(8-cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid tert-butyl ester |
1941177-45-2 |
C29H37N7O3 |
 |
Cabozantinib impurity 1 |
748707-58-6 |
C17H16N2O3 |
 |
Amlodipine Impurity 19 |
|
C26H31ClN2O8S |
 |
Amlodipine Impurity 9 |
90445-05-9 |
C26H31ClN2O8S |
 |
Clopidogrel Impurity 7 |
444728-13-6 |
C15H15ClN2OS |
 |
Rivaroxaban Impurity 36 |
1770812-39-9 |
C19H17Cl2N3O5S |
 |
(S)-methyl 2-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methylamino)-3-methylbutanoate |
1111177-24-2 |
C20H23N5O2 |
 |
Clopidogrel Impurity C |
1346605-15-9 |
C16H18ClNO2S |
 |
Nilotinib genotoxic impurity 2 |
1157857-29-8 |
C19H15F3N4O3 |
 |
Isavuconazole Impurity 48 |
|
|
 |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-hydroxyquinolin-2(1H)-one) |
|
|
![2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid](/CAS/20181212/GIF/CB39996369.gif) |
2-(4-(2-(4-(1-(2-methoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |
|
C27H35N3O3 |
 |
Tafluprost Impurity 19 |
|
|
 |
Rosuvastatin Impurity 162 |
|
|
 |
Rosuvastatin Impurity 151 |
|
|
 |
Rosuvastatin Impurity 148 |
|
|
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
![1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid](/CAS2/GIF/1163685-30-0.gif) |
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid |
1163685-30-0 |
C14H11N3O3 |
 |
O-Desethyl Candesartan Cilexetil |
869631-11-8 |
C31H30N6O6 |
 |
Epi Lovastatin |
79952-44-6 |
C24H36O5 |
 |
Hydroxy Brimonidine |
1216379-05-3 |
C11H12BrN5O |
 |
7-メトキシ-3,4-ジヒドロキノリン-2(1H)-オン |
22246-17-9 |
C10H11NO2 |
 |
N-ベンジル-1-(4-メトキシフェニル)プロパン-2-アミン塩酸塩 |
1049695-95-5 |
C17H21NO.HCl |
 |
モンテルカストメチルケトン |
937275-23-5 |
C34H32ClNO3S |
 |
Propyl Itraconazole |
74855-91-7 |
C34H36Cl2N8O4 |
 |
3-methyleneisobenzofuran-1(3H)-one |
3453-63-2 |
C9H6O2 |
 |
Irbesartan impurity A |
|
C25H28N6O |
![(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine](/CAS/20180713/GIF/223673-35-6.gif) |
(N-tert-Butoxycarbonyl-N-[(1'R)-hydroxy-1-phenyl)ethyl])-4-nitrophenylethylaMine |
223673-35-6 |
C21H26N2O5 |
 |
Azelastine N-Oxide |
640279-88-5 |
C22H24ClN3O2 |
![N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン](/CAS/20180808/GIF/1453221-45-8.gif) |
N-2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチルシロドシン |
1453221-45-8 |
C35H41F6N3O6 |
 |
Gliclazide Impurity E |
|
|
 |
Ethyl 1-butanesulfonate |
2374-68-7 |
C6H14O3S |
 |
OLANEXIDINE intermediate |
60852-95-1 |
C10H20N4 |
 |
1H-Isoindole, octahydro-, trans- |
10479-63-7 |
C8H15N |
![1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI)](/CAS/20180601/GIF/155272-03-0.gif) |
1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |
155272-03-0 |
C18H20N4O4 |
 |
Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
181289-34-9 |
C9H17NO3 |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
 |
2-(ACETOXYMETHYL)-4-METHOXY-3,5-DIMETHYLPYRIDINE |
91219-90-8 |
C11H15NO3 |
 |
4,4'-(4H-1,2,4-TRIAZOL-4-YLMETHYLENE)BIS BENZONITRILE |
112809-52-6 |
C17H11N5 |
 |
Pregna-1,4,9(11)-triene-3,20-dione,21-(acetyloxy)-17-hydroxy-6-methyl-, (6a)- |
93239-37-3 |
C24H30O5 |
 |
Tadalafil EP impurity E |
|
|
![4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine](/CAS/20200611/GIF/134965-85-8.gif) |
4'-chloro-7H-4,7'-bipyrrolo[2,3-d]pyrimidine |
134965-85-8 |
C12H7ClN6 |
 |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
 |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
1388858-78-3 |
C19H23FN2O2 |
![1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one](/CAS/20200401/GIF/220182-11-6.gif) |
1,4,7,10-Tetraazabicyclo[8.2.2]tetradecan-11-one |
220182-11-6 |
C10H20N4O |
 |
Ropivacaine EP Impurity D |
98626-59-6 |
C16H24N2O |
 |
Bendamustine Impurity 16 |
914626-65-6 |
C19H18N6O4 |
 |
(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride |
959392-22-4 |
C18H19NOS |
 |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |
|
|
![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](/CAS/20210305/GIF/2459302-85-1.gif) |
2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- |
2459302-85-1 |
C21H27N7O3 |
 |
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) |
96946-55-3 |
C53H72N2O12+2 |
 |
Glycine, N-(2-aminobenzoyl)-, ethyl ester |
5973-34-2 |
C11H14N2O3 |
![3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン](/CAS/GIF/54528-00-6.gif) |
3,3a,4,5,6,6a-ヘキサヒドロシクロペンタ[c]ピロール-2(1H)-アミン |
54528-00-6 |
C7H14N2 |
 |
(S)-Methyl 2-aminobutanoate |
15399-22-1 |
C5H11NO2 |